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This study aimed to assess intra and inter-observer agreement when using the Spine Instability Neoplastic Score (SINS).

Methods 
Clinical data and imaging from 90 patients with biopsy-proven spinal metastases, were provided to 83 specialists in 44 hospitals across 14 Spanish regions. No assessment criteria were pre-established. Each clinician assessed the SINS score twice, with a minimum 6 week interval. Clinicians were blinded to assessments made by other specialists and to their own previous assessment. Intraclass Correlation Coefficient (ICC) was used to assess agreement on the SINS score. The kappa statistic was used to assess; agreement on the location of the most affected vertebral level; agreement on the SINS category (“stable”, “potentially stable” or “unstable”); and overall agreement with the classification established by a multidisciplinary tumor board. Subgroup analyses were performed by clinicians’ specialty (medical oncology, neurosurgery, radiology, orthopedic surgery and radiation oncology), experience (≤7, 8-13, ≥14 years), and hospital category (four levels according to size and complexity).

Results
Intra and inter-observer agreement on the location of the most affected levels was “almost perfect” (κ>0.94). Intra-observer agreement on the SINS score was “excellent” (ICC=0.77), while inter-observer agreement was “moderate” (ICC=0.55). Intra-observer agreement in SINS category was “substantial” (k=0.61), while inter-observer was “moderate” (k=0.42). Overall agreement with the tumor board classification was “substantial” (κ=0.61). Results were similar across specialties, years of experience and hospital category. 

Conclusion






The organ most commonly affected by metastatic cancer is the skeleton, which is also where it causes the highest morbidity.1 There is controversy on the exact definition of spinal instability caused by spine metastatic disease, and the appropriate management.2 Several scoring systems have been proposed to standardize the diagnosis of “spinal instability” in these patients, and selecting those in whom surgery should be considered.3–5 However, only 14% of British clinicians managing spine metastatic disease are familiar with the available scoring systems.6 

The Spinal Instability Neoplastic Score (SINS) is based on clinical data and imaging findings (Table 1), and has been suggested as the most straightforward scoring system.7 It was originally developed by spine surgeons, and very few studies have analyzed its reliability when used by different specialists.8–10 None have included physicians from all the specialties involved in the management of spine metastatic disease.

Assessing the reliability of SINS across the different specialists involved in the assessment of spine metastatic disease, may contribute to improving the decision making process on the most suitable treatment for each patient.






Study design and participants

This prospective study was approved by the institutional review boards of the participating hospitals, and complied with the Guidelines for Reporting Reliability and Agreement Studies (GRRAS).11

Selection of Hospital Departments and clinicians

At the design phase of this study, the medical specialties considered to be relevant for the management of spine metastatic spine disease, were listed as follows: neurosurgery, medical oncology, radiation oncology, radiology and orthopedic surgery.

All of the 61 Hospital Departments specializing in these clinical areas, which had previously participated in studies undertaken by the Spanish Back Pain Research Network or had expressed interest in doing so, were invited to participate in this study. Twelve Departments were located in six private hospitals and the other 71 in 37 non for profit Hospitals, belonging to, or working for, the Spanish National Health Service (SNHS). The SNHS is the tax-funded, government-run, organization which provides free health care to every resident in Spain. 

The SNHS classifies Hospitals in five categories, based on the size of the catchment area, number of beds, number of clinicians, availability of high tech medical equipment and procedures, education, training and academic activity, and clinical complexity of the cases treated (i.e., being the “reference hospital” for specific diseases or procedures).12 Category 1 is the simplest and category 5 is the most complex. Departments invited to participate were located in hospitals belonging to categories 2, 3, 4 and 5. 

All clinicians who had finished their residency and worked at the participating departments were invited to act as readers in this study. Those who accepted were asked to provide the number of years they had been working in clinical practice after their residency. The Departments and clinicians did not receive any compensation for participating in this study.

Selection of patients and images

Patients and images were selected by a radiologist who worked in a category 4 hospital and did not act as a reader in this study. He revised consecutive patients in whom a tumor board (composed by a medical oncologist, a radiation oncologist, an orthopedic surgeon, a radiologist, and a pathologist, none of whom acted as readers in this study) had established the diagnosis of spine metastatic disease at ≥ 2 spine levels and had assessed the SINS score. These cases were revised in reverse chronological order (i.e., more recent cases were revised first). 

All images were acquired on the same CT and MRI systems with the same technique. The radiologist selected four images per patient; two CT scans and two MRI images, comprising at least two spine levels.





The recruiting radiologist prepared an information pack on each patient, comprising the four images and a clinical vignette stating patient’s age, oncologic history, clinical signs and symptoms, and whether the patient suffered from movement-related pain (Appendix Fig. A1).8 Patient identity was masked and a code was assigned to each information pack. All the information packs were uploaded onto an online platform specifically designed for this study (http://www.typeform.com/ (​http:​/​​/​www.typeform.com​/​​)). 

Each reader was provided with a personal password to access the information packs online. For each patient, readers were asked to report all the spinal levels in which they detected metastases (cervical, thoracic, lumbar, and/or sacral) and to calculate the SINS score based on the segment which they considered to be most affected (i.e., the “target” vertebral level; e.g., L1-L2). Readers were only provided with definitions included in the SINS (Table 1). No attempt was made to further explain or standardize these definitions or to homogenize the diagnostic criteria, and readers did not receive any instructions regarding the interpretation of images. They were told to use their own clinical judgment when in doubt, as they would do in every-day, routine clinical practice. 

Readers assessed the information pack alone and on their own, and introduced the resulting report into the online platform. They were asked to assess the same clinical sets twice, with a minimum six-week interval. The software ensured that the minimum period was observed, and that readers had no access to their own previous reports or to their colleagues’ current or previous reports.





Sample size was calculated at 90 patients with spine metastatic disease, assuming an Intraclass Correlation Coefficient of 0.7, a width of the confidence interval of 0.15, and that at least 5 observers per specialty would be recruited.

In order to assess agreement in the SINS score, the Intraclass Correlation Coefficient (ICC) was calculated using a two way random-effects model. For intra-observer agreement, an ICC was calculated for each one of the 83 observers, and median and 5th and 95th percentiles were estimated. For inter-observer agreement, scores from the first round were analyzed, and the ICC and its 95% Confidence Interval (95% CI) were estimated. ICC values were categorized as showing reliability to be “excellent” (>0.75), “moderate” (0.4-0.75), or “poor” (<0.4).13 

The SINS scores were then collapsed into three categories according to the degree of stability they represent and the treatment they imply; “stable” (SINS score between 0 and 6), “potentially unstable” (7-12), or “unstable” (13–18).7 
The unstable spine levels in each patient were classified into four categories; cervical, thoracic, lumbar or sacral. 
To assess intra-observer agreement for each categorical variable, a kappa index was calculated for each one of the 83 readers, and median, 5th and 95th percentiles values were calculated. To assess inter-observer agreement, the corresponding kappa index was estimated and the 95% Confidence Interval (95% CI) was determined following the jackknife resampling method.14 A weighted-kappa approach, with a bi-squared weighting scheme, was used. Kappa values were categorized as “almost perfect” (0.81–1.00), “substantial” (0.61–0.80), “moderate” (0.41–0.60), “fair” (0.21–0.40), “slight” (0.00–0.20), and “poor” (< 0.00).15 

Subgroup analyses for each variable were performed, in which ICC and kappa values were calculated separately depending on medical specialty, hospital category and professional experience. Degree of professional experience was classified as “recently specialized” (≤ 7 years in practice, after residency), “experienced” (8-13 years), and “senior specialist” (≥ 14 years).

The SINS scores agreed by the tumor board, and subsequently classified as “stable”, “potentially unstable” or “unstable”, were used as the “gold standard” to assess overall agreement. The agreement between this gold standard and the median score for each image among the 83 readers, was calculated through the kappa statistic.






Eighty-three clinicians from the 61 Hospital Departments participated in this study; 23 radiologists, 22 radiation oncologists, 16 orthopedic surgeons, 14 neurosurgeons, and eight medical oncologists. They worked in 44 hospitals, across 14 out of the 17 Spanish regions. The first 90 patients selected by the recruiting radiologist (51 women and 39 men, mean age 60.8 years) complied with the inclusion criteria, and none were excluded. These 90 patients showed metastases in 182 spinal levels. Sixteen primary pathologies were represented with breast (n=37), prostate (n=16), lung (n=12) being most popular. Table 2 shows sample characteristics.

There were more than five readers for each specialty and degree of professional experience. However, only three readers worked at category 2 hospitals; therefore, agreement for this subgroup was not calculated (Tables 3-5). 

Intra-observer agreement on the SINS score was “excellent” (median ICC 0.767; 5th, 95th percentiles [0.538; 0.939]). Inter-observer agreement was “moderate” (0.546; 95% CI [0.476; 0.624]). The only exception found in subgroup analyses, was that intra-observer agreement was only “moderate” among medical and radiation oncologists, as well as among physicians with 8-13 years of experience (Table 3). 

When the SINS scores were grouped into categories (“stable”, “potentially unstable” or “unstable”), intra-observer agreement in classifying the patients into these categories  was “substantial” (median kappa 0.605; 5th, 95th percentiles [0.381; 0.880]) while inter-observer agreement was “moderate” (0.424; 95% CI [0.336; 0.524]). Subgroup analyses revealed the following exceptions; a) intra-observer agreement was only “moderate” among medical oncologists, radiation oncologists, physicians with ≤ 7 years of experience, and physicians working in hospitals in categories 3 and 5; b) inter-observer agreement was only “fair” among orthopedic surgeons, radiologists, physicians with ≥ 14 years of clinical experience, and physicians working in category 5 hospitals (Table 4).

Intra- and inter-observer agreement in the identification of the potentially unstable spinal level/s, based on the categories grouping the SINS scores, was “almost perfect” (median kappa 0.971; 5th, 95th percentiles [0.871; 1.000] and 0.944; 95% CI [0.922; 0.970], respectively). Subgroup analyses did not show any differences (Table 5). 





Results from this study show that there is a “moderate” inter-observer agreement in determining the SINS score and in using this score to classify patients into three categories according to spine stability. They also show that this classification largely matches the consensus-based classification established by a multi-disciplinary tumor board, and that there is an “almost perfect” agreement in the identification of the unstable spine levels in each patient (Tables 3-6). These results are generally consistent across all the specialties involved in managing spine metastatic disease, irrespective of the number of years of experience and the size and complexity of the hospitals where the specialists work. The excellent agreement in the selection of the target level is reassuring, since disagreement is the major source of variability when assessing oncology patients’ individual response to treatment.16 

Some previous studies found the inter-observer agreement in the SINS score to be “excellent”,8,10, 17–19 while this study only found “moderate” agreement. Differences in methods can account for this; the current study aimed to assess intra- and inter-observer agreement in conditions as close as possible to routine clinical practice; all patients showed metastases in at least two spine levels, and identification of the target vertebral level was based on clinical judgment, as in routine practice.16 Moreover, a high number of readers participated, they had different backgrounds and worked in hospitals which were located in different regions, most readers had never met their colleagues in person, and agreement was assessed among different readers, and not among their individual scores and their global mean score.8,18 Furthermore, contrarily to some previous studies, the current one did not implement any measures to improve agreement,20 such as training, offering a stipend to readers, agreeing on diagnostic criteria, or using standardized nomenclature linked to examples available online.13,19  

In fact, the “moderate” inter-observer agreement found when using the SINS score to assess spine instability, is in line with what has been found in spine imaging in general. “Moderate” agreement has been found among radiologists when assessing spine degenerative disease through MRI,23 and among spine surgeons when using a cervical injury nomenclature system,24 or assessing complex injuries of the lumbar spine.25 The most acknowledged classification of primary spinal tumors also leads to a “moderate” inter-observer agreement.26 

As opposed to what has been found in this study (Tables 3-5), a previous report found agreement to be higher among physicians with more years of experience.18 The fact that all physicians who participated in the current study had undergone ≥ 4 years of clinical training to become certified specialists, may account for this difference. Paradoxically, in the current study, the physicians with the highest degree of experience showed the smallest inter-observer agreement when their SINS ratings were collapsed into three categories. However, although their median kappa value was smaller than the one for physicians with less experience, the 5th-95th percentiles largely overlap (Table 4).

The assessment of imaging by spine surgeons is usually considered as the gold standard for deciding whether surgery is appropriate for a patient with metastatic spine disease,17 and a previous study found that the inter-observer agreement in the SINS score is higher among spine surgeons than among other specialists.18 This was not the case in the current study, where differences across specialties were inconsistent, small, and likely to be clinically meaningless (Tables 3-5).11 The large sample size in this study, the high number of participating clinicians from each specialty and the fact that, as opposed to other studies,8,18 none of the readers participated in the definition of the “gold standard”, and those who were not spine surgeons were specialists who also manage spine metastatic disease in routine practice, can account for this difference in results.

“Inter-observer agreement” does not necessarily mean “external validity”, since consensus may not represent the actual “truth”;27 sometimes clinicians agree on measures which are not evidence-based or effective.28 In fact, the correlation between imaging and histopathology findings is low in some types of cancer,29 differences between SINS classification and real surgical outcomes have been documented,10 and the intrinsic characteristics of some types of tumor make it impossible to achieve high levels of agreement in clinical decisions.30 Moreover, “agreement” when using a scoring system, does not necessarily mean that the recommended treatment is “appropriate” or that it will improve outcomes. 

Nevertheless, even though improvement in the quality of care does not necessarily translate immediately into better clinical results,31 good communication among the different specialists involved in the management of oncology patients leads to consistency of care, which is a prerequisite for effectiveness in oncology patients.32 Future studies should compare the reliability and prognostic validity of different scoring systems, such as the SINS and the Tainechi scores,33,3 and assess whether their use, or measures to improve inter-observer agreement, actually lead to improved outcomes.

This study has some potential limitations. Readers only analyzed four selected images per case. Providing all the readers with all the images available for each patient might have changed the degree of agreement. However, this is the usual procedure for assessing reliability,  since it ensures that all the readers analyze the same images.8,34 Agreement in every feature of the SINS was not analyzed, and some items have shown to lead to only poor to fair agreement,8, 10, 18 while others, such as vertebral osteolysis and kyphotic deformity, predict the occurrence of compression fracture after radiotherapy better than the whole SINS score.35–37 However, this study focused on the reliability of the global SINS score, which is the relevant feature for identifying patients eligible for surgery. 

All patients underwent MRI and CT imaging. CT imaging is more accurate than radiography for depicting bone quality,38 and agreement in the SINS score might have been different if the latter had been used.10,19 However, CT imaging is routinely used to assess spine metastatic disease within the SNHS and most Western countries. Readers were volunteers from each of the invited Hospital Departments, and were not randomly selected. Therefore, selection bias may exist; it is possible that physicians who agreed to participate in this study were those who were the most motivated or interested in spine metastatic disease.39 Should this be the case, agreement might be lower among other clinicians less familiar with spine metastatic disease, and it is impossible to completely rule out this possibility. Nevertheless, the number of participants was large, they came from different specialties and settings, and agreement was similar irrespective of the number of years of experience and across all types of hospitals.20  All of the above suggests that results from this study are valid in routine clinical practice. 







Appendix Fig. A1. An example of the information pack provided to readers for each patient.
Images corresponding to a 69 years old female, suffering from breast cancer, who reported continuous back pain without referred pain. She presented lung, liver and bone metastases. Please select the most unstable spine level and fill in the corresponding SINS scoring.
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Table 1. The SINS classification according to the Spine Oncology Study Group (SOSG).7

Location	Score
Junctional (occiput-C2, C7-T2, T11-L1, L5-S1)	3


















No collapse with > 50% body involved	1
None of the above	0
Posterolateral involvement of spinal elements†	
Bilateral	3
Unilateral	1
None of the above	0

*Pain improvement with recumbency and/or pain with movement/loading of spine.






Table 2. Sample characteristics
Hospitals1		44
	Degree of complexity2	
	   Category 2     	3 (6.8)
	   Category 3	11 (25)
	   Category 4	9 (20.4)
	   Category 5	21 (47.7)
	Management3	
	   Not for profit	38
	   For profit 	6
Departments1		61
	RadiologyRadiation oncologyOrthopedic surgeryNeurosurgeryMedical oncology	19 (31.1)11 (18.0)12 (19.7)12 (19.7)7 (11.5)
Readers1		83
	Specialty	
	    Radiology     Radiation oncology    Orthopedic surgery    Neurosurgery    Medical oncology	23 (27.7)22 (26.5)16 (19.3)14 (16.9)8 (9.6) 
	Years in practice (post-residency)	
	    ≤ 71    8 to 13    ≥ 14	27 (32.5)25 (30.1)31 (37.4)
	Setting 	
	   Category of hospital in which they work2	
	       Category 2       Category 3       Category 4       Category 5	3 (3.6) 25 (30.1)19 (22.9)36 (43.4)
	   Hospital management3	
	        Not for profit	71
	        For profit	12
Patients		90
	Age (years)4 	60.8 (12.3)
	Gender (males)1	39 (43.3)
	Location of metastases1	
	    Cervical	4 (4.4)
	    Cervical and thoracic	15 (16.7)
	    Cervical, thoracic and lumbar	1(1.1)
	    Cervical, thoracic, lumbar and sacral	2 (2.2)
	    Thoracic	18 (20)
	    Thoracic and lumbar	15 (16.7)
	    Thoracic, lumbar and sacral	24 (26.7)
	    Lumbar	5 (5.6)
	    Lumbar and sacral	6 (6.7)
		





2: Category of hospital; complexity (based on size, availability of high tech medical equipment and procedures, education activity, etc.) ranges from category 1 (the simplest -none of this type were included in this study) to category 5 (the most complex). See text for details.
3: Not for profit: Hospitals belonging to the Spanish National Health Service (SNHS) or to charities working for the SNHS. For profit: Hospitals privately own and managed.  
4: Mean (SD)




Table 3. Intra- e interobserver agreement on SINS score (0-18), as measured by ICC. 
	Intra-observer agreement*	Inter-observer agreement**
Global agreement	0.767 (0.538; 0.939)	0.546 (0.476; 0.624)
Subgroup analyses	
   By specialty	
      Orthopedic surgery	0.796 (0.456; 0.972)	0.629 (0.557; 0.704)
      Neurosurgery	0.763 (0.538; 0.827)	0.566 (0.488; 0.648)
      Medical oncology	0.687 (0.000; 0.768)	0.450 (0.364; 0.544)
      Radiation oncology	0.724 (0.531; 0.957)	0.513 (0.433; 0.599)
      Radiology	0.816 (0.627; 0.889)	0.622 (0.547; 0.699)
  By years of practice	
      ≤ 7	0.757 (0.456; 0.954)	0.511 (0.437; 0.594)
     8 to 13	0.732 (0.608; 0.880)	0.557 (0.480; 0.639)
     ≥ 14	0.799 (0.531; 0.972)	0.565 (0.491; 0.645)
  By setting (category of hospital)+	
     Category 2ɣ	---	---
     Category 3	0.748 (0.456; 0.854)	0.514 (0.439; 0.597)
     Category 4	0.805 (0.538; 0.972)	0.563 (0.485; 0.646)
     Category 5	0.760 (0.590; 0.957)	0.556 (0.483; 0.636)
*: ICC values: median (5th; 95th percentiles)
**: Individual ICC value (95% confidence interval)
+: Complexity (based on size, availability of high tech medical equipment and procedures, education activity, etc.) ranges from category 1 (the simplest -none of this category were included in this study) to category 5 (the most complex). See text for details.




Table 4. Intra- and interobserver agreement on SINS category among the 83 clinicians, as measured by kappa values
	Intraobserver agreement*	Interobserver agreement**
Global agreement	0.605 (0.381; 0.880)	0.424 (0.336; 0.524)
Subgroup analyses	
   By specialty	
      Orthopedic surgery	0.675 (0.455; 1.000)	0.399 (0.053; 0.870)
      Neurosurgery	0.634 (0.389; 0.825)	0.497 (0.307; 0.753)
      Medical oncology	0.509 (0.066; 0.596)	0.429 (0.183; 0.813)
      Radiation oncology	0.578 (0.381; 0.937)	0.462 (0.234; 0.759)
      Radiology	0.646 (0.460; 0.799)	0.328 (0.205; 0.486)
  By years of practice	
      ≤ 7	0.594 (0.358; 0.934)	0.410 (0.228; 0.641)
     8 to 13	0.619 (0.423; 0.800)	0.511 (0.329; 0.743)
     ≥ 14	0.633 (0.365; 1.000)	0.345 (0.239; 0.477)
  By setting (category of hospital)+	
     Category 2ɣ	---	---
     Category 3	0.580 (0.353; 0.780)	0.425 (0.245; 0.655)
     Category 4	0.665 (0.389; 1.000)	0.530 (0.310; 0.819)
     Category 5	0.595 (0.418; 0.937)	0.372 (0.249; 0.523)
*: κ values: median (5th; 95th percentiles)
**: κ value (95% confidence interval)
+: Complexity (based on size, availability of high tech medical equipment and procedures, education activity, etc.) ranges from category 1 (the simplest -none of this category were included in this study) to category 5 (the most complex). See text for details.





Table 5. Agreement in the spinal levels involved, as measured by the kappa statistic

	Intraobserver agreement*	Interobserver agreement**
Global agreement	0.971 (0.871; 1.000)	0.944 (0.922; 0.970)
Subgroup analyses	
   By specialty	
      Orthopedic surgery	0.956 (0.813; 1.000)	0.923 (0.871; 0.997)
      Neurosurgery	0.972 (0.927; 1.000)	0.907 (0.814; 1.000)
      Medical oncology	0.909 (0.813; 0.956)	0.894 (0.763; 1.000)
      Radiation oncology	0.970 (0.891; 1.000)	0.974 (0.953; 1.000)
      Radiology	0.986 (0.944; 1.000)	0.964 (0.930; 1.000)
  By years of practice	
      ≤ 7	0.971 (0.826; 1.000)	0.908 (0.856; 0.976)
     8 to 13	0.971 (0.926; 1.000)	0.973 (0.953; 0.997)
     ≥ 14	0.970 (0.906; 1.000)	0.954 (0.920; 0.999)
  By setting (category of hospital)+	
     Category 2ɣ	---	---
     Category 3	0.971 (0.871; 1.000)	0.931 (0.892; 0.981)
     Category 4	0.972 (0.813; 1.000)	0.973 (0.948; 1.000)
     Category 5	0.970 (0.863; 1.000)	0.954 (0.924; 0.994)
*: κ values: median (5th; 95th percentiles)
**: κ value (95% confidence interval)
+: Complexity (based on size, availability of high tech medical equipment and procedures, education activity, etc.) ranges from category 1 (the simplest -none of this category were included in this study) to category 5 (the most complex). See text for details.









Median SINS  score	Stable(≤6)	5(35.7 %)	0(0.0 %)	0(0.0 %)	5
	Potentially unstable (7-12)	9(64.3%)	59(98.3 %)	5(31.2 %)	73
	Unstable (≥13)	0(0.0%)	1(1.7 %)	11(68.8 %)	12
Total		14	60	16	90
*: Predictive validity (kappa value): 0.610 (95% CI, 0.437; 0.792)
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